Table 1.
Patient characteristics (demographical, clinical, and laboratory results).
| Survivors No. = 487 (90%) |
Non-Survivors No. = 51 (10%) |
p | |
|---|---|---|---|
| Demographical data | |||
| Sex (M/F) | 371 (77%)/116 (23%) | 42 (82%)/9 (18%) | 0.589 |
| Age (years) | 64 (60–71) | 67 (62–72) | 0.161 |
| Co-morbidities | |||
| Arterial hypertension (n (%)) | 379 ((71%) | 40 (78%) | 0.109 |
| Diabetes mellitus (n (%)) | 175 (33%) | 16 (31%) | 0.676 |
| Hypercholesterolemia (n (%)) | 298 (55%) | 29 (57%) | 0.173 |
| COPD (n (%)) | 47 (9%) | 12 (24%) | <0.001 * |
| PAD (n (%)) | 80 (15%) | 16 (31%) | <0.001 * |
| Kidney failure (n (%)) | 29 (6%) | 3 (6%) | 0.768 |
| Laboratory tests: | |||
| WBC × 109/L (median (Q1–Q3)) | 7.8 (6.4–9.3) | 7.5 (6.4–8.9) | 0.388 |
| Lymphocytes × 109/L (median (Q1–Q3)) | 1.8 (1.4–2.2) | 1.7 (1.3–2.0) | 0.092 |
| Neutrophils × 109/L (median (Q1–Q3)) | 5 (4–6.3) | 5.1 (4.2–6.1) | 0.886 |
| NLR (median (Q1–Q3)) | 2.8 (2–3.7) | 2.8 (2.1–4.0) | 0.235 |
| Hb × 109/L (median (Q1–Q3)) | 8.7 (8.2–9.2) | 8.6 (7.9–9.3) | 0.658 |
| Platelets × 103/μL (median (Q1–Q3)) | 225 (190–267) | 230 (202–261) | 0.456 |
| Monocytes × 109/L (median (Q1–Q3)) | 0.5 (0.4–0.6) | 0.5 (0.3–0.6) | 0.877 |
| MLR (median (Q1–Q3)) | 0.3 (0.2–0.4) | 0.3 (0.2–0.4) | 0.113 |
| MCHC (mmol/L) (median (Q1–Q3)) | 21.3 (20.8–21.7) | 21 (20.6–21.1) | 0.037 |
| PLR (median (Q1–Q3)) | 125 (98–163) | 140 (114–167) | 0.027 * |
| Troponin I (ng/mL) (median (Q1–Q3)) | 0.01 (0.01–0.02) | 0.02 (0.01–0.03) | 0.13 |
| Creatinine (mg/dL) (median (Q1–Q3)) | 85 (72–102) | 99 (67–132) | 0.044 * |
| SIRI (median (Q1–Q3) | 1.3 (0.8–1.9) | 1.3 (0.9–2.1) | 0.261 |
| SII (median (Q1–Q3)) | 618 (424–903) | 668 (445–982) | 0.174 |
| AISI (median (Q1–Q3)) | 273 (172–440) | 308 (185–489) | 0.199 |
Abbreviations: AISI—aggregate index of systemic inflammation, COPD—chronic obstructive pulmonary disease, Hb—hemoglobin, LV—left ventricle, LVEF—left ventricle ejection fraction, MCHC—mean corpuscular hemoglobin concentration, MLR—monocyte-to-lymphocyte ratio, NLR—neutrophil-to-lymphocyte ratio, PAD—peripheral artery disease, PLR—platelets-to-lymphocyte ratio, SII—systemic inflammatory index, SIRI—systemic inflammatory response index, WBC—white blood cells. * Statistically significant difference. Continuous variables are expressed as the medians with the lower and the upper quartile, whereas categorical variables are expressed as (n) with a percentage (%).